COMP <GO>
DOV vs TMO // PIOTROSKI F-SCORE QUALITY
Dover Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: DOV 8
— TMO 5
■ METRIC PARITY
LAST: $207.74 (-1.25%) • MKT CAP: $27.98B
piotroski-score
8/9
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DOV VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DOV | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.80% | 41.00% | -1.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.90% | 9.30% | +3.60 | DOV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.6x | 30.4x | -11.80 | DOV | /valuation <GO> |
| Free Cash Flow Yield | 3.67% | 2.40% | +1.27 | DOV | /fcf-yield <GO> |
| Operating Margin | 17.00% | 17.40% | -0.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 13.50% | 15.10% | -1.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 4.50% | 3.90% | +0.60 | DOV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 0.24% | +0.77 | DOV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.21 | 4.50 | +0.71 | DOV | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.5 | 59.1 | +8.36 | DOV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.94 | -0.01 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.8x | 36.3x | -12.50 | DOV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.98B | $262.22B | -$234.24B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DOV REV | TMO REV | DOV GROSS % | TMO GROSS % | DOV FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.09B | $44.56B | 39.8% | 44.0% | $1.00B | $6.29B |
| FY 2024 | $7.75B | $42.88B | 38.2% | 44.0% | $2.85B | $7.27B |
| FY 2023 | $7.68B | $42.86B | 44.0% | 44.0% | $990.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DOV // BETA 0.93
TMO // BETA 0.94